New Agents

Research into new physical or chemical means to treat disease.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1937-2016
051019372015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
To discover new agents active against methicillin-resistant Staphylococcus aureus (MRSA), in silico models derived from 5451 cell… (More)
Is this relevant?
2013
2013
Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2012
2012
OPINION STATEMENT The treatment of migraine was advanced dramatically with the introduction of triptans in the early 1990s… (More)
Is this relevant?
2011
2011
Glioblastoma is the most common malignant glioma in adults, and despite recent advances in standard treatment, the prognosis… (More)
Is this relevant?
2008
2008
Despite both the increase in basic biologic knowledge and the fact that many new agents have reached various stages of… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
1999
Review
1999
In the early drug development process for cancer therapy, several ethical dilemmas result from the use of cancer patients with… (More)
Is this relevant?
1997
1997
We report a multicentre phase II study of orally administered prolonged schedule etoposide in children with refractory or… (More)
Is this relevant?
Review
1996
Review
1996
Standardization of terminology used to describe the pattern and course of MS is essential for mutual understanding between… (More)
Is this relevant?
1991
1991
Fludarabine Monophosphate (FLU) is an adenosine analogue with a high-level of anti-leukemic activity in patients (pts) with CLL… (More)
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?